Elizabeth E Blue1, Andréa R V R Horimoto2, Shubhabrata Mukherjee3, Ellen M Wijsman4, Timothy A Thornton5. 1. Division of Medical Genetics, University of Washington, Seattle, WA, USA. Electronic address: em27@uw.edu. 2. Department of Biostatistics, University of Washington, Seattle, WA, USA. 3. Department of Medicine, University of Washington, Seattle, WA, USA. 4. Division of Medical Genetics, University of Washington, Seattle, WA, USA; Department of Biostatistics, University of Washington, Seattle, WA, USA; Department of Genome Sciences, University of Washington, Seattle, WA, USA. 5. Department of Biostatistics, University of Washington, Seattle, WA, USA; Department of Statistics, University of Washington, Seattle, WA, USA. Electronic address: tathornt@uw.edu.
Abstract
INTRODUCTION: Although the relationship between APOE and Alzheimer's disease (AD) is well established in populations of European descent, the effects of APOE and ancestry on AD risk in diverse populations is not well understood. METHODS: Logistic mixed model regression and survival analyses were performed in a sample of 3067 Caribbean Hispanics and 3028 individuals of European descent to assess the effects of APOE genotype, local ancestry, and genome-wide ancestry on AD risk and age at onset. RESULTS: Among the Caribbean Hispanics, individuals with African-derived ancestry at APOE had 39% lower odds of AD than individuals with European-derived APOE, after adjusting for APOE genotype, age, and genome-wide ancestry. While APOE E2 and E4 effects on AD risk and age at onset were significant in the Caribbean Hispanics, they were substantially attenuated compared with those in European ancestry individuals. DISCUSSION: These results suggest that additional genetic variation in the APOE region influences AD risk beyond APOE E2/E3/E4.
INTRODUCTION: Although the relationship between APOE and Alzheimer's disease (AD) is well established in populations of European descent, the effects of APOE and ancestry on AD risk in diverse populations is not well understood. METHODS: Logistic mixed model regression and survival analyses were performed in a sample of 3067 Caribbean Hispanics and 3028 individuals of European descent to assess the effects of APOE genotype, local ancestry, and genome-wide ancestry on AD risk and age at onset. RESULTS: Among the Caribbean Hispanics, individuals with African-derived ancestry at APOE had 39% lower odds of AD than individuals with European-derived APOE, after adjusting for APOE genotype, age, and genome-wide ancestry. While APOE E2 and E4 effects on AD risk and age at onset were significant in the Caribbean Hispanics, they were substantially attenuated compared with those in European ancestry individuals. DISCUSSION: These results suggest that additional genetic variation in the APOE region influences AD risk beyond APOE E2/E3/E4.
Authors: E E Blue; C-E Yu; T A Thornton; N H Chapman; E Kernfeld; N Jiang; K M Shively; K J Buckingham; C T Marvin; M J Bamshad; T D Bird; E M Wijsman Journal: Genes Brain Behav Date: 2017-11-20 Impact factor: 3.449
Authors: A Goate; M C Chartier-Harlin; M Mullan; J Brown; F Crawford; L Fidani; L Giuffra; A Haynes; N Irving; L James Journal: Nature Date: 1991-02-21 Impact factor: 49.962
Authors: Jun Z Li; Devin M Absher; Hua Tang; Audrey M Southwick; Amanda M Casto; Sohini Ramachandran; Howard M Cann; Gregory S Barsh; Marcus Feldman; Luigi L Cavalli-Sforza; Richard M Myers Journal: Science Date: 2008-02-22 Impact factor: 47.728
Authors: L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn Journal: JAMA Date: 1997 Oct 22-29 Impact factor: 56.272
Authors: Vladimir N Babenko; Dmitry A Afonnikov; Elena V Ignatieva; Anton V Klimov; Fedor E Gusev; Evgeny I Rogaev Journal: BMC Neurosci Date: 2018-04-19 Impact factor: 3.288
Authors: Becca R Levy; Martin D Slade; Robert H Pietrzak; Luigi Ferrucci Journal: J Gerontol B Psychol Sci Soc Sci Date: 2020-09-14 Impact factor: 4.077
Authors: Aziz M Mezlini; Colin Magdamo; Emily Merrill; Lori B Chibnik; Deborah L Blacker; Bradley T Hyman; Sudeshna Das Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: Ian S Arriaga-MacKenzie; Gregory Matesi; Samuel Chen; Alexandria Ronco; Katie M Marker; Jordan R Hall; Ryan Scherenberg; Mobin Khajeh-Sharafabadi; Yinfei Wu; Christopher R Gignoux; Megan Null; Audrey E Hendricks Journal: Am J Hum Genet Date: 2021-06-21 Impact factor: 11.025
Authors: Maria Victoria Marca-Ysabel; Farid Rajabli; Mario Cornejo-Olivas; Patrice G Whitehead; Natalia K Hofmann; Maryenela Zaida Illanes Manrique; Diego Martin Veliz Otani; Ana Karina Milla Neyra; Sheila Castro Suarez; Maria Meza Vega; Larry D Adams; Pedro R Mena; Isasi Rosario; Michael L Cuccaro; Jeffery M Vance; Gary W Beecham; Nilton Custodio; Rosa Montesinos; Pilar E Mazzetti Soler; Margaret A Pericak-Vance Journal: Neurobiol Aging Date: 2020-12-10 Impact factor: 4.673
Authors: Eric McDade; Jorge J Llibre-Guerra; David M Holtzman; John C Morris; Randall J Bateman Journal: Mol Neurodegener Date: 2021-07-21 Impact factor: 14.195
Authors: Dallas P Veitch; Michael W Weiner; Paul S Aisen; Laurel A Beckett; Charles DeCarli; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Susan M Landau; John C Morris; Ozioma Okonkwo; Richard J Perrin; Ronald C Petersen; Monica Rivera-Mindt; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; Duygu Tosun; John Q Trojanowski Journal: Alzheimers Dement Date: 2021-09-28 Impact factor: 16.655
Authors: Young Won Kim; Ismael Al-Ramahi; Amanda Koire; Stephen J Wilson; Daniel M Konecki; Samantha Mota; Shirin Soleimani; Juan Botas; Olivier Lichtarge Journal: Alzheimers Dement Date: 2020-12-07 Impact factor: 21.566